Add to ORKGGonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysi
Background: Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone ...
Androgen deprivation is the mainstay therapy for metastatic prostate cancer (PCa). Another way of su...
Hormonal manipulation plays a significant role in the treatment of advanced hormone naïve prostate c...
Objectives To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists comp...
Objectives: To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists com...
Prostate cancer is the second most common cause of cancer-related deaths in men, representing a majo...
Androgen deprivation therapy (ADT) is the main treatment approach in advanced prostate cancer and in...
Abstract Background This study was performed to examine the usefulness of combined androgen blockade...
Castration remains the mainstay of treatment in the management of metastatic prostate cancer. Medica...
Purpose: To compare luteinizing hormone–releasing hormone (LHRH) agonists with orchiectomy or diethy...
# The Author(s) 2014. This article is published with open access at Springerlink.com Introduction Gn...
PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen depri...
BACKGROUND: Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone ...
Abstract: Manipulation of the hypothalamic-pituitary-gonadal axis via androgen deprivation therapy h...
Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides ...
Background: Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone ...
Androgen deprivation is the mainstay therapy for metastatic prostate cancer (PCa). Another way of su...
Hormonal manipulation plays a significant role in the treatment of advanced hormone naïve prostate c...
Objectives To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists comp...
Objectives: To evaluate efficacy and safety of gonadotropin-releasing hormone (GnRH) antagonists com...
Prostate cancer is the second most common cause of cancer-related deaths in men, representing a majo...
Androgen deprivation therapy (ADT) is the main treatment approach in advanced prostate cancer and in...
Abstract Background This study was performed to examine the usefulness of combined androgen blockade...
Castration remains the mainstay of treatment in the management of metastatic prostate cancer. Medica...
Purpose: To compare luteinizing hormone–releasing hormone (LHRH) agonists with orchiectomy or diethy...
# The Author(s) 2014. This article is published with open access at Springerlink.com Introduction Gn...
PURPOSE: Comparing gonadotrophin-releasing hormone (GnRH) antagonists and agonists as androgen depri...
BACKGROUND: Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone ...
Abstract: Manipulation of the hypothalamic-pituitary-gonadal axis via androgen deprivation therapy h...
Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides ...
Background: Gonadotropin releasing hormone (GnRH) antagonists suppress follicle-stimulating hormone ...
Androgen deprivation is the mainstay therapy for metastatic prostate cancer (PCa). Another way of su...
Hormonal manipulation plays a significant role in the treatment of advanced hormone naïve prostate c...